The most recent study by Tufts Center for the Study of Drug Development, puts the cost of bringing a medicine from invention to pharmacy shelves at $2.7bn. Imagine that drug had the power to improve patients daily lives, it might for example prevent infection, stop disease progression, or make debilitating symptoms or side effects manageable but nobody knew about it.
According to Med Comms network, “Medical research is meaningless unless it is communicated well to the right people.” In order for patients to receive that treatment and for it to be distributed on an appropriate scale, the pharmaceutical company needs to work with clinical experts to plan, to support and deliver well thought-out information and education to a variety of audiences. This is why medical communications is vitally important.
There are many platforms for medical communications professionals to exhibit their work, but the pinnacle of a medical writer’s career occurs when their work is published in an esteemed medical journal. Perhaps the most prominent publication is The Journal of the American Medical Association Established in 1883, it is the world’s most circulated journal and has around 1.2 million email subscribers who receive the table of contents free via email. The journal also receives around 15 million annual visits to its website.
There will be an abundance of work in the global medical communications market as there is a need for commercially available written material aimed at health practitioners and patients. The sector is poised to reach a market value of around $3.6bn by 2026 and will grow at CAGR above 9.7 % from 2019 to 2026, according a report from Acumen Research, entitled ‘Medical Writing Market’.